These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 24074715)

  • 1. [Non-canonical Wnt signaling contributes to development of non-alcoholic steatohepatitis in a rat model of type 2 diabetes mellitus].
    Tian F; Zhang YJ; Wang L
    Zhonghua Gan Zang Bing Za Zhi; 2013 Jul; 21(7):537-42. PubMed ID: 24074715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Celecoxib ameliorates non-alcoholic steatohepatitis in type 2 diabetic rats via suppression of the non-canonical Wnt signaling pathway expression.
    Tian F; Zhang YJ; Li Y; Xie Y
    PLoS One; 2014; 9(1):e83819. PubMed ID: 24404139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of celecoxib on expression of PPARγ and NF-κB in type 2 diabetes rats with non-alcoholic steatohepatitis].
    Tian F; Zhang YJ; Wang YH
    Zhonghua Gan Zang Bing Za Zhi; 2016 Aug; 24(8):590-595. PubMed ID: 27788706
    [No Abstract]   [Full Text] [Related]  

  • 4. [Development and evaluation of a high-fat/high-fructose diet-induced nonalcoholic steatohepatitis mouse model].
    Liu J; Liu Y; Wang W; Luo Y; Zhuang Z; Jiao Q; Chen J; Bian D; Ma X; Xun Y; Zhu M; Shi J
    Zhonghua Gan Zang Bing Za Zhi; 2014 Jun; 22(6):445-50. PubMed ID: 25203709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanism study of the protective effects of selective cyclooxygenase-2 enzyme inhibitors on the liver of rats with type 2 diabetes mellitus combined with nonalcoholic steatohepatitis via Rho/ROCK pathway].
    Yuan L; Tian F
    Zhonghua Gan Zang Bing Za Zhi; 2022 Jan; 30(1):74-80. PubMed ID: 35152673
    [No Abstract]   [Full Text] [Related]  

  • 6. [The relationship between the expression of NF-kB, TGFbeta1, FN and hepatic fibrosis in diabetic rats].
    Wang RR; Chen XY; Liao HL; Wan L; Li JM; Chen LL; Chen XF; Chen GR
    Zhonghua Gan Zang Bing Za Zhi; 2010 Mar; 18(3):194-8. PubMed ID: 20380796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of Nrf2 and related factors on the progression of nonalcoholic steatohepatitis].
    Cai YQ; Zhang LZ; Wang DJ; Chen FM; Chen ZY; Zhu KY; Li JS; Yan MX
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2014 Sep; 30(5):465-70. PubMed ID: 25571645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of telmisartan on nonalcoholic steatohepatitis rat model by activating peroxisome proliferator-activated receptor r].
    Liu JK; Shen YH; Liu XC; Zhang H; Wu H; Yin M
    Zhonghua Gan Zang Bing Za Zhi; 2011 Aug; 19(8):614-8. PubMed ID: 22152320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of quercetin on nuclear factor-κB p65 expression in renal ubiquitin-proteasome system of diabetic rats].
    Chen P; Chen JB; Chen WY; Zheng QL; Wang YQ; Xu XJ
    Zhonghua Nei Ke Za Zhi; 2012 Jun; 51(6):460-5. PubMed ID: 22943758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of nuclear factor-κB and angiotensin II receptor type 1 on the pathogenesis of rat non-alcoholic fatty liver disease.
    Tan DY; Shi HY; Li CP; Zhong XL; Kang M
    World J Gastroenterol; 2015 May; 21(19):5877-83. PubMed ID: 26019451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pioglitazone ameliorates nonalcoholic steatohepatitis by down-regulating hepatic nuclear factor-kappa B and cyclooxygenases-2 expression in rats.
    Zhao JS; Zhu FS; Liu S; Yang CQ; Chen XM
    Chin Med J (Engl); 2012 Jul; 125(13):2316-21. PubMed ID: 22882855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of zhenqing recipe on non-alcoholic fatty liver in type 2 diabetes rats and the expression of SIK1].
    Zheng H; Hong SC; Yu J; Wen XY
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Jul; 34(7):846-52. PubMed ID: 25137852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Total Flavone of Haw Leaves on Nuclear Factor Erythroid-2 Related Factor and Other Related Factors in Nonalcoholic Steatohepatitis Rats.
    Wang DJ; Cai YQ; Pan SZ; Zhang LZ; Chen YX; Chen FM; Jin M; Yan MX; Li XD; Chen ZY
    Chin J Integr Med; 2018 Apr; 24(4):265-271. PubMed ID: 26919834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Metformin prevents non-alcoholic fatty liver disease in rats: role of phospholipase A2/lysophosphatidylcholine lipoapoptosis pathway in hepatocytes].
    Huang Y; Fu JF; Shi HB; Liu LR
    Zhonghua Er Ke Za Zhi; 2011 Feb; 49(2):139-45. PubMed ID: 21426695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of Fuzi Lizhong decoction in reducing liver injury of rats with non-alcoholic fatty liver via activating AMPK and suppressing NF-κBp65 pathway].
    Yang JY; Shi ZH; Ma W; Tao DQ; Liu S; Chen L; Zhou XL
    Zhongguo Zhong Yao Za Zhi; 2018 Aug; 43(15):3176-3183. PubMed ID: 30200715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Female spontaneously diabetic Torii fatty rats develop nonalcoholic steatohepatitis-like hepatic lesions.
    Ishii Y; Motohashi Y; Muramatsu M; Katsuda Y; Miyajima K; Sasase T; Yamada T; Matsui T; Kume S; Ohta T
    World J Gastroenterol; 2015 Aug; 21(30):9067-78. PubMed ID: 26290633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of metabolic risk factors for developing nonalcoholic fatty liver in patients with type 2 diabetes mellitus].
    Guo M; Xi G; Yang N; Yao H
    Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):631-5. PubMed ID: 25243967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect and mechanism of ginsenoside Rg1 as an alcoholic hepatitis treatment in a rat model].
    Liu S; Huang W; Xin X; Zhao J; Shi Z; Liu C; Tang J
    Zhonghua Gan Zang Bing Za Zhi; 2015 Aug; 23(8):609-15. PubMed ID: 26447626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of action of gypenosides on type 2 diabetes and non-alcoholic fatty liver disease in rats.
    He Q; Li JK; Li F; Li RG; Zhan GQ; Li G; Du WX; Tan HB
    World J Gastroenterol; 2015 Feb; 21(7):2058-66. PubMed ID: 25717238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liraglutide in combination with human umbilical cord mesenchymal stem cell could improve liver lesions by modulating TLR4/NF-kB inflammatory pathway and oxidative stress in T2DM/NAFLD rats.
    Xu X; Wang W; Lin L; Chen P
    Tissue Cell; 2020 Oct; 66():101382. PubMed ID: 32933722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.